Uveal Melanoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Metastatic Uveal Melanoma
Conditions:   Uveal Melanoma;   Melanoma;   Metastatic Uveal Melanoma;   Metastatic Melanoma Intervention:   Biological: Lifileucel (LN-144) Sponsors:   Memorial Sloan Kettering Cancer Center;   Iovance Biotherapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2022 Category: Research Source Type: clinical trials

Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases.
Condition:   Uveal Melanoma Interventions:   Drug: Tislelizumab;   Drug: Sitravatinib Malate Sponsors:   Grupo Español Multidisciplinar de Melanoma;   Mirati Therapeutics Inc.;   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2022 Category: Research Source Type: clinical trials